Simulations Plus SLP Share-Based Payment Award Options Outstanding - Number

Share-Based Payment Award Options Outstanding - Number at other companies

NeoGenomicsNEO

9.6M+41.0%

Medpace Holdings, Inc.MEDP

——

Other financials

Income statement

See full

Revenue$24.3M+8.3%

Gross profit$16.1M+23.0%

Operating income$5.6M+108%

Net income$4.5M+47.5%

EPS (diluted)$0.22+46.7%

Balance sheet

See full

Cash & equivalents$25.7M+134%

Total debt$508.0K-36.2%

Total equity$133.8M-29.4%

Total assets$146.5M-27.3%

Cash flow

See full

Operating cash flow$6.4M+13.1%

CapEx$46.0K-30.3%

Free cash flow$6.4M+13.6%

Valuation

See full

Market cap$366.73M+5.2%

Enterprise value$341.51M+6.0%

P/S4.6×+0.2×

Profitability

See full

Gross margin62%+6.7pp

Operating margin-84.3%—

Net margin-78%-87.2pp

FCF margin29.5%+14.9pp

Returns & leverage

See full

Return on equity-38.8%-42.8pp

Debt / equity0×0.0×

Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Simulations Plus’s 10-Q, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's share-based payment award options outstanding - number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Simulations Plus's share-based payment award options outstanding - number?: Simulations Plus (SLP) reported share-based payment award options outstanding - number of 2.4M in Q4 2025.
What does share-based payment award options outstanding - number mean?: This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.